MEDICINES CO (MDCO) Stock Price, Quote, News and Overview
NASDAQ:MDCO - Nasdaq -
MDCO Quote, Performance and Key Statistics
84.9
-0.06 (-0.07%)
The current stock price of MDCO is 84.9 null. In the past month the price increased by 0.99%. In the past year, price increased by 356.21%.
About MDCO
Company Profile
The Medicines Company is a biopharmaceutical company driven by an overriding purpose-to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in two critical therapeutic areas: serious infectious disease care and cardiovascular care. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in serious infectious disease care and cardiovascular care.
Company Info
MEDICINES CO
8 SYLVAN WAY
PARSIPPANY NJ 07054
CEO: Mark Timney
Phone: 973-290-6000
MEDICINES CO / MDCO FAQ
What is the stock price of MEDICINES CO today?
The current stock price of MDCO is 84.9 null. The price decreased by -0.07% in the last trading session.
What is the ticker symbol for MEDICINES CO stock?
The exchange symbol of MEDICINES CO is MDCO and it is listed on the Nasdaq exchange.
On which exchange is MDCO stock listed?
MDCO stock is listed on the Nasdaq exchange.
What is MEDICINES CO worth?
MEDICINES CO (MDCO) has a market capitalization of 6.77B null. This makes MDCO a Mid Cap stock.
What are the support and resistance levels for MEDICINES CO (MDCO) stock?
MEDICINES CO (MDCO) has a support level at 84.89 and a resistance level at 84.91. Check the full technical report for a detailed analysis of MDCO support and resistance levels.
Should I buy MEDICINES CO (MDCO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MDCO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MDCO, evaluating the profitability, health, valuation and growth aspects
- MEDICINES CO (MDCO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MEDICINES CO (MDCO) Sales and EPS estimates to see what analysts future expectations are.
- MEDICINES CO (MDCO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MEDICINES CO (MDCO) Insider and Institutional Ownership to learn about the owners and their transactions.
- MEDICINES CO (MDCO) Stock Chart to make your own analysis
- MEDICINES CO (MDCO) Latest news and press-releases to stay up to date.
Does MEDICINES CO (MDCO) stock pay dividends?
MDCO does not pay a dividend.
What is the Price/Earnings (PE) ratio of MEDICINES CO (MDCO)?
MEDICINES CO (MDCO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.98).
MDCO Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to MDCO. When comparing the yearly performance of all stocks, MDCO is one of the better performing stocks in the market, outperforming 99.5% of all stocks.
MDCO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MDCO. MDCO has a bad profitability rating. Also its financial health evaluation is rather negative.
MDCO Financial Highlights
Over the last trailing twelve months MDCO reported a non-GAAP Earnings per Share(EPS) of -2.98. The EPS increased by 32.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.35% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
MDCO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 69% to MDCO. The Buy consensus is the average rating of analysts ratings from 9 analysts.